Literature DB >> 9848890

Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia.

T J Smilde1, F W van den Berkmortel, G H Boers, H Wollersheim, T de Boo, H van Langen, A F Stalenhoef.   

Abstract

Recent developments in ultrasound technology enable the noninvasive measurement of structural and functional vessel wall changes. Until now, the effect of homocysteine on the arterial wall has remained unclear: reports on intima-media thickness (IMT) yield conflicting results, whereas data on vessel wall stiffness are lacking. Because several cardiovascular risk factors result in an increased IMT or stiffness, different groups at risk for atherosclerotic disease, with special emphasis on hyperhomocysteinemia, were studied. Nineteen patients homozygous and 14 subjects heterozygous for cystathionine beta-synthase (CBS) deficiency, 21 patients with familial hypercholesterolemia (FH), 15 patients with essential hypertension, 20 smokers, and 28 control subjects were studied. The IMT values (both right and left) of the common carotid artery (CCA), bulb (BUL), internal carotid artery (ICA), and common femoral artery (CFA) were measured in millimeters by high-resolution ultrasound (Biosound). The distensibility (DC, in 10(-3). kPa-1) and compliance (CC in mm2. kPa-1) coefficients of the CCA (right and left) and CFA (right) were determined by a wall track system (Pie Medical). The mean IMT of the posterior wall in the CCA was 0.70+/-0.09 mm in healthy controls. For patients with vascular disease, FH, and hypertension and in smokers, the mean CCA IMT was larger, whereas no major differences in IMT were observed in patients either homozygous or heterozygous for CBS deficiency. The DC and CC in the right CCA were 23.5+/-6.9 (10(-3). kPa-1) and 0.9+/-0.3 (mm2. kPa-1) in healthy subjects, slightly lower in patients homozygous for CBS deficiency, and clearly lower in patients with vascular disease, FH, and hypertension. No positive correlation was found between plasma homocysteine level and either IMT, CC, or DC. Because smoking was a confounder in each risk group, a stepwise regression analysis was carried out to assess the contribution of each risk factor on IMT and arterial wall stiffness. Age explained most of the variation in IMT of the CCA (coefficient of determination R2 of 0.34), whereas R2 values for serum low density lipoprotein cholesterol, smoking (pack-years), and systolic blood pressure were 0.08, 0.07, and 0.06, respectively. Homocysteine did not contribute to variation in IMT in both the CCA and CFA. Age and smoking contributed to the variation in IMT in the CFA. The variation in DC and CC in the right CCA and right CFA could in part be explained by age, low density lipoprotein cholesterol, and blood pressure. Plasma homocysteine concentration explained only a small proportion of the variation in DC in the CCA (R2=0.02) and in CC in the CFA (R2=0.04). In this study, no relationship was found between homocysteine level and the thickness of the arterial wall, with only a marginal influence on stiffness.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848890     DOI: 10.1161/01.atv.18.12.1958

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

1.  D919G polymorphism of methionine synthase gene is associated with blood pressure response to benazepril in Chinese hypertensive patients.

Authors:  Yan Zhang; Minmin Zhang; Tianhua Niu; Xin Xu; Guoying Zhu; Yong Huo; Changzhong Chen; Xiaobin Wang; Houxun Xing; Shaojie Peng; Aiqun Huang; Xiumei Hong; Xiping Xu
Journal:  J Hum Genet       Date:  2004-05-18       Impact factor: 3.172

2.  Effects of cold pressor-induced sympathetic stimulation on the mechanical properties of common carotid and femoral arteries in healthy males.

Authors:  Jie Liu; Tie-Sheng Cao; Yun-You Duan; Yi-Lin Yang; Li-Jun Yuan
Journal:  Heart Vessels       Date:  2010-12-22       Impact factor: 2.037

3.  Mesenteric vascular remodeling in hyperhomocysteinemia.

Authors:  C Munjal; S Givvimani; N Qipshidze; N Tyagi; J C Falcone; S C Tyagi
Journal:  Mol Cell Biochem       Date:  2010-11-13       Impact factor: 3.396

4.  3-Deazaadenosine mitigates arterial remodeling and hypertension in hyperhomocysteinemic mice.

Authors:  Alexander V Ovechkin; Neetu Tyagi; Utpal Sen; David Lominadze; Mesia M Steed; Karni S Moshal; Suresh C Tyagi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-06-30       Impact factor: 5.464

Review 5.  Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.

Authors:  D A Stehouwer
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

6.  Effect of blood flow on double inversion recovery vessel wall MRI of the peripheral arteries: quantitation with T2 mapping and comparison with flow-insensitive T2-prepared inversion recovery imaging.

Authors:  Ryan Brown; Thanh D Nguyen; Pascal Spincemaille; Matthew D Cham; Grace Choi; Priscilla A Winchester; Martin R Prince; Yi Wang
Journal:  Magn Reson Med       Date:  2010-03       Impact factor: 4.668

Review 7.  Homocysteine and blood pressure.

Authors:  Coen van Guldener; Prabath W B Nanayakkara; Coen D A Stehouwer
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

8.  Rationale, Design and Baseline Characteristics of a Clinical Trial Comparing the Effects of Robust vs Conventional Cholesterol Lowering and Intima Media Thickness in Patients with Familial Hypercholesterolaemia : The Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) Study.

Authors:  T J Smilde; M D Trip; H Wollersheim; S van Wissen; J J Kastelein; A F Stalenhoef
Journal:  Clin Drug Investig       Date:  2000       Impact factor: 2.859

9.  Hyperhomocysteinemia induced by methionine supplementation does not independently cause atherosclerosis in C57BL/6J mice.

Authors:  Ji Zhou; Geoff H Werstuck; Sárka Lhoták; Yuan Y Shi; Vivienne Tedesco; Bernardo Trigatti; Jeffrey Dickhout; Alana K Majors; Patricia M DiBello; Donald W Jacobsen; Richard C Austin
Journal:  FASEB J       Date:  2008-03-25       Impact factor: 5.191

10.  Current Status of Drug-Eluting Stents and Drug-Eluting Balloons for the Superficial Femoral Artery.

Authors:  Joy P Walker; Christopher D Owens
Journal:  Curr Surg Rep       Date:  2013-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.